- Home
- FBRX vs PMI Comparison
FBRX vs PMI Comparison
Compare FBRX & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- PMI
- Stock Information
- Founded
- FBRX N/A
- PMI 1981
- Country
- FBRX United States
- PMI United States
- Employees
- FBRX N/A
- PMI N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- PMI
- Sector
- FBRX Health Care
- PMI
- Exchange
- FBRX Nasdaq
- PMI Nasdaq
- Market Cap
- FBRX 170.0M
- PMI 202.7M
- IPO Year
- FBRX N/A
- PMI 2025
- Fundamental
- Price
- FBRX $18.56
- PMI $2.27
- Analyst Decision
- FBRX Strong Buy
- PMI
- Analyst Count
- FBRX 3
- PMI 0
- Target Price
- FBRX $68.00
- PMI N/A
- AVG Volume (30 Days)
- FBRX 108.4K
- PMI 627.7K
- Earning Date
- FBRX 11-14-2025
- PMI 11-14-2025
- Dividend Yield
- FBRX N/A
- PMI N/A
- EPS Growth
- FBRX N/A
- PMI N/A
- EPS
- FBRX N/A
- PMI N/A
- Revenue
- FBRX N/A
- PMI $4,767,000.00
- Revenue This Year
- FBRX N/A
- PMI N/A
- Revenue Next Year
- FBRX N/A
- PMI N/A
- P/E Ratio
- FBRX N/A
- PMI N/A
- Revenue Growth
- FBRX N/A
- PMI 8.81
- 52 Week Low
- FBRX $4.90
- PMI $2.20
- 52 Week High
- FBRX $28.68
- PMI $13.68
- Technical
- Relative Strength Index (RSI)
- FBRX 66.60
- PMI N/A
- Support Level
- FBRX $18.11
- PMI N/A
- Resistance Level
- FBRX $21.99
- PMI N/A
- Average True Range (ATR)
- FBRX 1.78
- PMI 0.00
- MACD
- FBRX 0.70
- PMI 0.00
- Stochastic Oscillator
- FBRX 73.74
- PMI 0.00
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.